Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Inflammatory Bowel Diseases

  Free Subscription

Articles published in Clin Exp Immunol

Retrieve available abstracts of 6 articles:
HTML format

Single Articles

    September 2022
  1. HU M, Chen Z, Liao Y, Wu J, et al
    Clinical value of the expression levels of protein tyrosine phosphatase non-receptor type 22.6 mRNA in peripheral blood mononuclear cells in Crohn's disease.
    Clin Exp Immunol. 2022;209:311-315.
    PubMed     Abstract available

    June 2022
  2. MA K, Que W, Hu X, Guo WZ, et al
    Combinations of anti-GITR antibody and CD28 superagonist ameliorated dextran sodium sulfate-induced mouse colitis.
    Clin Exp Immunol. 2022;208:340-350.
    PubMed     Abstract available

  3. SHARIFINEJAD N, Zaki-Dizaji M, Sepahvandi R, Fayyaz F, et al
    The clinical, molecular, and therapeutic features of patients with IL10/IL10R deficiency: a systematic review.
    Clin Exp Immunol. 2022;208:281-291.
    PubMed     Abstract available

    May 2021
  4. QIAN K, Yuan L, Wang S, Kuang Y, et al
    Inhibitor of apoptosis stimulating p53 protein (iASPP) protects against inflammatory bowel disease (IBD) in mice models by inhibiting the NF-kappaB signaling.
    Clin Exp Immunol. 2021 May 3. doi: 10.1111/cei.13613.
    PubMed     Abstract available

    February 2021
  5. LAN X, Liu F, Ma J, Chang Y, et al
    Leukocyte immunoglobulin-like receptor A3 is increased in IBD patients and functions as an anti-inflammatory modulator.
    Clin Exp Immunol. 2021;203:286-303.
    PubMed     Abstract available

    June 2020
  6. SHAMRIZ O, Simon AJ, Lev A, Megged O, et al
    Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation.
    Clin Exp Immunol. 2020;200:215-227.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.